Title:
SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING A PSYCHIATRIC DISORDER
Document Type and Number:
WIPO Patent Application WO/2022/054987
Kind Code:
A1
Abstract:
The present invention relates to a pharmaceutical composition for treating and/or alleviating a psychiatric disorder comprising a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a pharmaceutical composition for inducing anti-stress, anti-anxiety and/or anti-depressant activities comprising a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient.
Inventors:
CHOI YONG MOON (US)
Application Number:
PCT/KR2020/012237
Publication Date:
March 17, 2022
Filing Date:
September 10, 2020
Export Citation:
Assignee:
BIO PHARM SOLUTIONS CO LTD (KR)
International Classes:
C07D317/18; A61K31/357; A61P25/00; C07D317/72
Domestic Patent References:
| WO2010011548A1 | 2010-01-28 |
Foreign References:
| US20180230090A1 | 2018-08-16 | |||
| US20160310461A1 | 2016-10-27 | |||
| US20090247616A1 | 2009-10-01 | |||
| US20030078213A1 | 2003-04-24 |
Attorney, Agent or Firm:
ERUUM & LEEON INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF:
Previous Patent: MOBILE TERMINAL
Next Patent: TERMINAL, CONTROL METHOD THEREFOR, AND RECORDING MEDIUM IN WHICH PROGRAM FOR IMPLEMENTING METHOD IS ...
Next Patent: TERMINAL, CONTROL METHOD THEREFOR, AND RECORDING MEDIUM IN WHICH PROGRAM FOR IMPLEMENTING METHOD IS ...